All Phenotypes Gt(ROSA)26Sor<tm4(EWSR1/ATF1)Mrc> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}
targeted mutation 4, Mario R Capecchi
MGI:5495288

Summary

11 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺	involves: C57BL/6	MGI:5495300
cn2	Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:5495301
cn3	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Bmi1^{tm1(cre/ERT)Mrc}/Bmi1⁺	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:5495321
cn4	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Pax7^tm1(cre)Mrc/Pax7⁺	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:5495314
cn5	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Myf5^tm1(cre)Mrc/Myf5⁺	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:5495318
cn6	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Pax7^{tm1(cre/ERT2)Gaka}/Pax7⁺	involves: 129S6/SvEvTac * C57BL/6	MGI:5495319
cn7	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Pax3^tm1(cre)Joe/Pax3⁺	involves: C57BL/6	MGI:5495303
cn8	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Tg(Prrx1-cre/ERT2)1Mlgn/?	involves: C57BL/6	MGI:5495320
cn9	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺	involves: C57BL/6J * CBA/J	MGI:5495316
cn10	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Tg(Prrx1-cre)1Cjt/?	involves: C57BL/6 * SJL	MGI:5495317
cn11	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Tg(Tek-cre)1Ywa/?	involves: C57BL/6 * SJL	MGI:5495315

Allelic Composition	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺
Genetic Background	involves: C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc} mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased incidence of tumors by chemical induction ( J:194308 )

• injection of TAT-cre results in tumors at the injection site as well as EGFP expression

abnormal tumor morphology ( J:194308 )

• match human clear cell sarcoma tumor histomorphology and immunochemistry

• open chromatin and clear cytoplasm

increased tumor growth/size ( J:194308 )

• rapid tumor growth after visible detection regardless of latency

abnormal tumor latency ( J:194308 )

• latency of tumor formation correlated with TAT-cre concentration

homeostasis/metabolism

increased incidence of tumors by chemical induction ( J:194308 )

• injection of TAT-cre results in tumors at the injection site as well as EGFP expression

Allelic Composition	Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^{tm1(cre/ERT)Nat} mutation (2 available); any Gt(ROSA)26Sor mutation (993 available)
Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc} mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

decreased litter size ( J:194308 )

growth/size/body

postnatal growth retardation ( J:194308 )

• administration of tamoxifen prior to 3 weeks of age results in stunted growth

mortality/aging

premature death ( J:194308 )

• administration of tamoxifen prior to 3 weeks of age results in death by 12 weeks of age without tumor formation

neoplasm

increased tumor incidence ( J:194308 )

• when tamoxifen is administered after 3 weeks of age more tumors form than without tamoxifen

• tumors most often in extremities, rib cage, and facial tissue

• tumors rare in dermis, liver, and bone

increased sarcoma incidence ( J:217462 )

• mice develop clear cell sarcoma mimicking tumors across a broad anatomic distribution at 3-6 months of age in the absence of tamoxifen, indicating leakiness of the cre transgene

increased tumor latency ( J:194308 )

• all mice have tumors by 12 weeks regardless of treatment

Allelic Composition	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Bmi1^{tm1(cre/ERT)Mrc}/Bmi1⁺
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Bmi1^{tm1(cre/ERT)Mrc} mutation (2 available); any Bmi1 mutation (31 available)
Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc} mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:194308 )

• fully penetrant tumorigenesis when tamoxifen is injected after 3 weeks of age

• tumors in deep mesenchymal tissues of the limbs and trunk

• most tumors form adjacent to bone but some are totally in muscle

• all tumors with "clear cell" morphology

Allelic Composition	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Pax7^tm1(cre)Mrc/Pax7⁺
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc} mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Pax7^tm1(cre)Mrc mutation (2 available); any Pax7 mutation (38 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

lethality throughout fetal growth and development, complete penetrance ( J:194308 )

• live embryos at E18.5 but no live progeny

craniofacial

abnormal craniofacial morphology ( J:194308 )

• severe craniofacial deformation

Allelic Composition	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Myf5^tm1(cre)Mrc/Myf5⁺
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc} mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Myf5^tm1(cre)Mrc mutation (1 available); any Myf5 mutation (17 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:194308 )

• live to 3 months

growth/size/body

decreased body size ( J:194308 )

• mice are very small

muscle

myopathy ( J:194308 )

• severely myopathic

Allelic Composition	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Pax7^{tm1(cre/ERT2)Gaka}/Pax7⁺
Genetic Background	involves: 129S6/SvEvTac * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc} mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Pax7^{tm1(cre/ERT2)Gaka} mutation (1 available); any Pax7 mutation (38 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

muscle

myopathy ( J:194308 )

• when tamoxifen is administered after 3 weeks of age myopathy develops by 12 months

neoplasm

neoplasm ( J:194308 )

N	• no abnormal tumor development when treated with tamoxifen after 3 weeks of age

Allelic Composition	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Pax3^tm1(cre)Joe/Pax3⁺
Genetic Background	involves: C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc} mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Pax3^tm1(cre)Joe mutation (1 available); any Pax3 mutation (50 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality, complete penetrance ( J:194308 )

Allelic Composition	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Tg(Prrx1-cre/ERT2)1Mlgn/?
Genetic Background	involves: C57BL/6

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

muscle

myopathy ( J:194308 )

• when tamoxifen is administered after 3 weeks of age myopathy develops by 12 months

neoplasm

increased tumor incidence ( J:194308 )

• when tamoxifen is administered after 3 weeks of age tumors develop in the extremities of 100% of mice by 8 weeks of age

• tumors arise from the periosteal/perichondrial layer as well as within musculature

• clear cell morphology or spindle cell morphology

Allelic Composition	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺
Genetic Background	involves: C57BL/6J * CBA/J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc} mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
H2az2^{Tg(Wnt1-cre)11Rth} mutation (2 available); any H2az2 mutation (26 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality, complete penetrance ( J:194308 )

Allelic Composition	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Tg(Prrx1-cre)1Cjt/?
Genetic Background	involves: C57BL/6 * SJL

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

lethality throughout fetal growth and development, complete penetrance ( J:194308 )

• embryos are viable at E14.5 but with severe limb deformities

limbs/digits/tail

abnormal limb morphology ( J:194308 )

• severe limb deformities at E14.5

Allelic Composition	Gt(ROSA)26Sor^{tm4(EWSR1/ATF1)Mrc}/Gt(ROSA)26Sor⁺ Tg(Tek-cre)1Ywa/?
Genetic Background	involves: C57BL/6 * SJL

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality, complete penetrance ( J:194308 )

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 09/03/2024 MGI 6.24